NiKem Research receives certification for GLP Bioanalysis
NiKem Research announced that it has received, from the Italian Ministry of Health, GLP certification of its bioanalysis facilities to further extend its drug discovery service capabilities.
NiKem Research has provided for many years bioanalytical support both for its in vitro ADME(T) and in vivo PK services associated to various drug discovery programs and as a standalone capability. The company is now able to offer bioanalysis as a GLP service to support clients preclinical PK and toxicology studies.
Giuseppe Giardina, CEO & Managing Director of NiKem, said “This new product is an important step in NiKem’s continuing expansion of its high quality, cost effective services to support progression of our clients’ drug discovery programmes”.
Organizations
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Nanotube-producing bacteria show manufacturing promise - Nanotubes may have high-tech applications, study involving UCR engineers reports
Sequencing of cacao genome will help US chocolate industry, subsistence farmers

A New Open-Source Tool for Analyzing Complex Health Data - Sort, group, and analyze large, heterogeneous, and complex datasets without any pre-existing hypotheses

Study of skin biopsies offers potential as new diagnostic marker for Amyotrophic Lateral Sclerosis - The discovery of this biomarker detectable in small skin samples can be very useful for cases in which diagnosis is difficult
